Psychosomatic approach to clinical practice

Somatization and Psychosomatic Symptoms

Volumn , Issue , 2013, Pages 75-90

  Tossani, Eliana ^a   Fava, Giovanni Andrea ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928126785     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-7119-6_7     Document Type: Chapter

References (113)

1. Lipowski, Z. J. (1986). Psychosomatic medicine: Past and present. Part II. Current state. Canadian Journal of Psychiatry, 31, 8-13.
2. Fava, G. A., & Sonino, N. (2010). Psychosomatic medicine. International Journal of Clinical Practice, 64, 1155-1161.
3. Wise, T. N. (2010). Psychosomatic medicine: An approach needed now more than ever. International Journal of Clinical Practice, 64, 999-1001.
4. Fava, G. A., & Sonino, N. (2010). Psychosomatic medicine: A name to keep. Psychotherapy and Psychosomatics, 79, 1-3.
5. Fava, G. A., Sonino, N., & Wise, T. N. (Eds.). (2012). The psychosomatic assessment. Strategies to improve clinical practice (Advances in psychosomatic medicine, Vol. 32). Basel, Switzerland: Karger.
6. Kroenke, K. (2002). Psychological medicine. BMJ, 324, 1536-1537.
7. Novack, D. H., Cameron, O., Epel, E., et al. (2007). Psychosomatic medicine: The scientific foundation of the biopsychosocial model. Academic Psychiatry, 31, 388-401.
8. McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological Reviews, 87, 873-904.
9. Fava, G. A., Guidi, J., Semprini, F., et al. (2010). Clinical assessment of allostatic load and clinimetric criteria. Psychotherapy and Psychosomatics, 79, 280-284.
10. McCauley, J., Kern, D. E., Kolodner, K., et al. (1997). Clinical characteristics of women with a history of childhood abuse. JAMA: The Journal of the American Medical Association, 277, 1362-1368.
11. Romans, S., & Cohen, M. (2008). Unexplained and underpowered: The relationship between psychosomatic disorders and interpersonal abuse. Harvard Review of Psychiatry, 16, 35-44.
12. McEwen, B. S., & Stellar, E. (1993). Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine, 153, 2093-2101.
13. Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99, 2192-2217.
14. Sonino, N., Tomba, E., & Fava, G. A. (2007). Psychosocial approach to endocrine disease. Advances in Psychosomatic Medicine, 28, 21-33.
15. Wright, R. J., Rodriguez, M., & Cohen, S. (1998). Review of psychosocial stress and asthma. Thorax, 53, 1066-1074.
16. Picardi, A., & Abeni, D. (2001). Stressful life events and skin disease. Psychotherapy and Psychosomatics, 70, 118-136.
17. Mokdad, A. H., Marks, J. S., Stroup, D. F., et al. (2004). Actual causes of death in the United States, 2000. JAMA: The Journal of the American Medical Association, 291, 1238-1245.
18. World Health Organization. (1948). Constitution of the World Health Organization basic document. Geneva, Switzerland: Author.
19. Ryff, C. D., & Singer, B. (1996). Psychological well-being. Psychotherapy and Psychosomatics, 65, 14-23.
20. Caprara, G. V., Alessandri, G., & Barbaranelli, C. (2010). Optimal functioning. Psychotherapy and Psychosomatics, 79, 328-330.
21. Pressman, S. D., & Cohen, S. (2005). Does positive affect influence health? Psychological Bulletin, 131, 925-971.
22. Chida, Y., & Steptoe, A. (2008). Positive psychological well-being and mortality. Psychosomatic Medicine, 70, 741-756.
23. Shah, S. U., White, A., White, S., et al. (2004). Heart and mind: (1) Relationship between cardiovascular and psychiatric conditions. Postgraduate Medical Journal, 80, 683-689.
24. Taylor, G. J. (2010). Affects, trauma, and mechanisms of symptom formation. A tribute to John C. Nemiah, MD (1918-2009). Psychotherapy and Psychosomatics, 79, 339-349.
25. Prince, M., Patel, V., Saxena, S., et al. (2007). No health without mental health. Lancet, 370, 859-877.
26. Pohle, K., Domscheke, K., Roehrs, T., et al. (2009). Medical comorbidity affects antidepres-sant treatment response in patients with melancholic depression. Psychotherapy and Psychosomatics, 78, 359-363.
27. Sonino, N., Fava, G. A., & Fallo, F. (2010). Psychosomatic aspects of Cushing's syndrome. Reviews in Endocrine & Metabolic Disorders, 11, 95-104.
28. Aj, M., Vaze, A., & Rao, S. (2009). Clinical diagnosis of depression in primary care: A meta-analysis. Lancet, 374, 609-619.
29. Mitchell, A. J., Rao, S., & Vaze, A. (2010). Do primary care physicians have particular dif-ficulty identifying late-life depression? A meta-analysis stratified by age. Psychotherapy and Psychosomatics, 79, 285-294.
30. Katon, W. J. (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry, 54, 216-226.
31. Schulz, R., Drayer, R. A., & Rollman, B. L. (2002). Depression as a risk factor for non-suicide mortality in the elderly. Biological Psychiatry, 52, 205-225.
32. di Matteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101-2107.
33. Frasure-Smith, N., & Lesperance, F. (2003). Depression and other psychological risks following myocardial infarction. Archives of General Psychiatry, 60, 627-636.
34. Lemogne, C., Nabi, H., Zins, M., et al. (2010). Hostility may explain the association between depressive mood and mortality: Evidence from the French GAZEL cohort study. Psychotherapy and Psychosomatics, 79, 164-171.
35. Dirmaier, J., Watzke, B., Koch, U., et al. (2010). Diabetes in primary care: Prospective associations between depression, nonadherence and glycemic control. Psychotherapy and Psychosomatics, 79, 172-178.
36. Kojima, M., Hayano, J., Suzuki, S., et al. (2010). Depression, alexithymia and long-term mortality in chronic hemodialysis patients. Psychotherapy and Psychosomatics, 79, 303-311.
37. Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., et al. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30, 208-225.
38. Fava, G. A., Porcelli, P., Rafanelli, C., et al. (2010). The spectrum of anxiety disorders in the medically ill. The Journal of Clinical Psychiatry, 71, 910-914.
39. Beutel, M. E., Bleichner, F., von Heymann, F., et al. (2010). Anxiety disorders and comorbidity in psychosomatic inpatients. Psychotherapy and Psychosomatics, 79, 58.
40. Fava, G. A., Fabbri, S., Sirri, L., et al. (2007). Psychological factors affecting medical condition: A new proposal for DSM-V. Psychosomatics, 48, 103-111.
41. Porcelli, P., & Sonino, N. (Eds.). (2007). Psychological factors affecting medical conditions. A new classification for DSM-V. Basel, Switzerland: Karger.
42. Wise, T. N. (2009). Diagnostic criteria for psychosomatic research are necessary for DSM-V. Psychotherapy and Psychosomatics, 78, 330-332.
43. Porcelli, P., Bellomo, A., Quartesan, R., et al. (2009). Psychosocial functioning in consultation-liaison psychiatry patients. Psychotherapy and Psychosomatics, 78, 352-358.
44. Fava, G. A., & Wise, T. N. (2007). Psychological factors affecting either identified or feared medical conditions: A solution for somatoform disorders. The American Journal of Psychiatry, 164, 1002-1003.
45. Kellner, R. (1994). Psychosomatic syndromes, somatization and somatoform disorders. Psychotherapy and Psychosomatics, 61, 4-24.
46. Engel, G. L. (1970). Conversion symptoms. In C. M. Mac Bryde & R. S. Blacklow (Eds.), Signs and symptoms (pp. 650-699). Philadelphia: Lippincott.
47. Goldbeck, R. (1997). Denial in physical illness. Journal of Psychosomatic Research, 43, 575-593.
48. Cockram, C. A., Doros, G., & de Figueiredo, J. M. (2009). Diagnosis and measurement of subjective incompetence: The clinical hallmark of demoralization. Psychotherapy and Psychosomatics, 78, 342-345.
49. Mangelli, L., Fava, G. A., Grandi, S., et al. (2005). Assessing demoralization and depression in the setting of medical disease. The Journal of Clinical Psychiatry, 66, 391-394.
50. Sirri, L., Fava, G. A., & Wise, T. N. (2011). Psychiatric classification in the setting of medical disease: Comparing the clinical value of different proposals. Journal of Psychosomatic Research, 70, 493-495.
51. Mangelli, L., Fava, G. A., Grassi, L., et al. (2006). Irritable mood in Italian patients with medical disease. The Journal of Nervous and Mental Disease, 194, 226-228.
52. Härter, M., Baumeister, H., Reuter, K., et al. (2007). Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics, 76, 354-360.
53. Tinetti, M. E., & Fried, T. (2004). The end of the disease era. American Journal of Medicine, 116, 179-185.
54. Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196, 129-136.
55. Fava, G. A., & Sonino, N. (2009). Psychosomatic assessment. Psychotherapy and Psychosomatics, 78, 333-341.
56. Sonino, N., & Peruzzi, P. (2009). A psychoneuroendocrinology service. Psychotherapy and Psychosomatics, 78, 346-351.
57. Lipowski, Z. J. (1974). Physical illness and psychopathology. International Journal of Psychiatry in Medicine, 5, 483-497.
58. Feinstein, A. R. (1982). The Jones criteria and the challenge of clinimetrics. Circulation, 66, 1-5.
59. Feinstein, A. R. (1987). Clinimetrics. New Haven, CT: Yale University Press.
60. Fava, G. A., Tomba, E., & Sonino, N. (2012). Clinimetrics: The science of clinical measurements. International Journal of Clinical Practice, 66, 11-15.
61. Fava, G. A., Rafanelli, C., & Tomba, E. (2012). The clinical process in psychiatry: A clini-metric approach. The Journal of Clinical Psychiatry, 73, 177-184.
62. Feinstein, A. R. (1970). The pre-therapeutic classification of comorbidity in chronic disease. Journal of Chronic Diseases, 23, 455-468.
63. deGroot, V., Beckerman, H., Lankhorst, G. J., et al. (2003). How to measure comorbidity: A critical review of available methods. Journal of Clinical Epidemiology, 56, 221-229.
64. Emmelkamp, P. M. G., Bouman, T. K., & Scholing, A. (1993). Anxiety disorders (pp. 55-67). Chichester, England: Wiley.
65. Emmelkamp, P. M. G. (2004). The additional value of clinimetrics needs to be established rather than assumed. Psychotherapy and Psychosomatics, 73, 142-144.
66. Joosten, E. A. G., De Fuentes-Merillas, L., de Weert, G. H., et al. (2008). Systematic review of the effects of shared-decision making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics, 77, 219-226.
67. Joosten, E. A. G., de Jong, C. A. J., de Weert-van Oene, G. H., et al. (2009). Shared decision making reduces drug use and psychiatry severity in substance-dependent patients. Psychotherapy and Psychosomatics, 78, 245-253.
68. Fava, G. A., & Kellner, R. (1993). Staging: A neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 87, 225-230.
69. Feinstein, A. R. (1973). An analysis of diagnostic reasoning. I The domains and disorders of clinical macrobiology. The Yale Journal of Biology and Medicine, 46, 212-232.
70. Engel, G. L. (1967). The concept of psychosomatic disorder. Journal of Psychosomatic Research, 11, 3-9.
71. Aaron, L. A., & Buchwald, D. (2001). A review of the evidence for overlap among unexplained clinical conditions. Annals of Internal Medicine, 134, 868-881.
72. Fava, G. A., Tomba, E., & Grandi, S. (2007). The road to recovery from depression. Psychotherapy and Psychosomatics, 76, 260-265.
73. Fava, G. A., Grandi, S., Rafanelli, C., et al. (2000). Explanatory therapy of hypochondriasis. The Journal of Clinical Psychiatry, 61, 317-322.
74. Fava, G. A., & Tomba, E. (2009). Increasing psychological well-being and resilience by psychotherapeutic methods. Journal of Personality, 77, 1903-1934.
75. Feinstein, A. R. (1973). An analysis of diagnostic reasoning. II. The strategy of intermediate decisions. The Yale Journal of Biology and Medicine, 46, 264-283.
76. Feinstein, A. R. (1999). Basic biomedical science and the destruction of the pathophysio-logical bridge from bench to bedside. American Journal of Medicine, 107, 461-467.
77. Dantzer, R. (2005). Somatization: A psychoneuroimmune perspective. Psychoneuroendocri-nology, 30, 947-952.
78. Price, D. D., Finniss, D. G., & Benedetti, F. (2008). A comprehensive review of the placebo effect. Annual Review of Psychology, 59, 565-590.
79. Walach, H., Bosch, H., Lewith, G., et al. (2008). Effectiveness of distant healing for patients with chronic fatigue syndrome. Psychotherapy and Psychosomatics, 77, 158-166.
80. Thayer, J. F., & Brosschot, J. F. (2005). Psychosomatics and psychopathology. Psychoneuroendocrinology, 30, 1050-1058.
81. Tak, L. M., Janssens, K. A., Dietrich, A., et al. (2010). Age-specific associations between cardiac vagal activity and functional somatic symptoms: A population-based study. Psychotherapy and Psychosomatics, 79, 179-187.
82. Zachariae, R., Paulsen, K., Mehlsen, M., et al. (2007). Chemotherapy-induced nausea, vomiting and fatigue. Psychotherapy and Psychosomatics, 76, 376-384.
83. Bech, P. (2009). Fifty years with the Hamilton Scales for anxiety and depression. Psychotherapy and Psychosomatics, 78, 202-211.
84. Carroll, B. J. (1994). Brain mechanisms in manic depression. Clinical Chemistry, 40, 303-308.
85. Fava, G. A. (1987). Irritable mood and physical illness. Stress Medicine, 3, 293-299.
86. Kamarck, T. W., Haskett, R. F., Muldoon, M., et al. (2009). Citalopram intervention for hostility. Journal of Consulting and Clinical Psychology, 77, 174-188.
87. Charney, D. S. (2004). Psychobiological mechanisms of resilience and vulnerability. The American Journal of Psychiatry, 161, 195-216.
88. Cloninger, C. R. (1987). Systematic method for clinical description and classification of personality. Archives of General Psychiatry, 44, 573-588.
89. Fava, M., Littman, A., & Halperin, P. (1987). Neuroendocrine correlates of the type A behavior pattern. International Journal of Psychiatry in Medicine, 17, 289-307.
90. Rapp, M. A., Rieckmann, N., Lessman, D. A., et al. (2010). Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: A pilot study. Psychotherapy and Psychosomatics, 79, 149-155.
91. Lichtenberg, P., & Belmaker, R. H. (2010). Subtyping major depressive disorder. Psychotherapy and Psychosomatics, 79, 131-135.
92. Bech, P. (2010). The struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychotherapy and Psychosomatics, 79, 331-338.
93. Baumeister, H., & Parker, G. (2010). A second thought on subtyping major depression. Psychotherapy and Psychosomatics, 79, 388-389.
94. Guidi, J., Fava, G. A., Picardi, A., et al. (2011). Subtyping depression in the medically ill by cluster analysis. Journal of Affective Disorders, 132, 383-388.
95. Fava, G. A., Guidi, J., Porcelli, P., et al. (2012). A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill. Psychological Medicine, 42, 401-407.
96. Tomba, E. (2012). Assessment of lifestyle in relation to health. Advances in Psychosomatic Medicine, 32, 72-96.
97. Narayan, K. M. V., Kanaya, A. M., & Gregg, E. W. (2003). Lifestyle intervention for the prevention of type 2 diabetes mellitus. Treatments in Endocrinology, 2, 315-320.
98. Compas, B. E., Haagon, D. A., Keefe, F. J., et al. (1998). Sampling of empirically supported psychological treatments from health psychology: Smoking, chronic pain, cancer, and bulimia nervosa. Journal of Consulting and Clinical Psychology, 66, 89-112.
99. Bodenheimer, T., Lorig, K., Holman, H., et al. (2002). Patient self-management of chronic disease in primary care. JAMA: The Journal of the American Medical Association, 288, 2469-2475.
100. Jackson, J. L., de Zee, K., & Berbano, E. (2004). Can treating depression improve disease outcomes? Annals of Internal Medicine, 140, 1054-1056.
101. Pigott, H. E., Leventhal, A. M., Alter, G. S., et al. (2010). Efficacy and effectiveness of antidepressants. Psychotherapy and Psychosomatics, 79, 267-279.
102. Balon, R. (2009). Cognitive-behavioral therapy, psychotherapy and psychosocial interventions in the medically ill. Psychotherapy and Psychosomatics, 78, 261-264.
103. Kaupp, J. W., Rapaport-Hubschman, N., & Spiegel, D. (2005). Psychosocial treatments. In J. L. Levenson (Ed.), Textbook of psychosomatic medicine (pp. 923-956). Washington, DC: American Psychiatric Press.
104. Abbass, A., Kisely, S., & Kroenke, K. (2009). Short-term psychodynamic psychotherapy for somatic disorders. Psychotherapy and Psychosomatics, 78, 265-274.
105. Andersen, B. L., Yang, H. C., Farrar, W. B., et al. (2008). Psychologic intervention improves survival for breast cancer patients. Cancer, 113, 3450-3458.
106. Herschbach, P., Berg, P., Waadt, S., et al. (2010). Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychotherapy and Psychosomatics, 79, 31-38.
107. Grassi, L., Sabato, S., Rossi, E., et al. (2010). Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: A pilot study. Psychotherapy and Psychosomatics, 79, 39-47.
108. Tulipani, C., Morelli, F., Spedicato, M. R., et al. (2010). Alexithymia and cancer pain: The effect of psychological intervention. Psychotherapy and Psychosomatics, 79, 156-163.
109. Turk, D. C., Swanson, K. S., & Tunks, E. R. (2008). Psychological approaches in the treatment of chronic pain patients. Canadian Journal of Psychiatry, 53, 213-223.
110. Lahmann, C., Nickel, M., Schuster, T., et al. (2009). Functional relaxation and guided imagery as complementary therapy in asthma: A randomized controlled clinical trial. Psychotherapy and Psychosomatics, 78, 233-239.
111. Frisina, P. G., Borod, J. C., & Lepore, S. J. (2004). A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. The Journal of Nervous and Mental Disease, 192, 629-634.
112. van Middendorp, H., Geenen, R., Sorbi, M. J., et al. (2009). Health and physiological effects of an emotional disclosure intervention adapted for application at home: A randomized clinical trial in rheumatoid arthritis. Psychotherapy and Psychosomatics, 78, 145-151.
113. Sirri, L., Grandi, S., & Fava, G. A. (2008). The illness attitude scales. Psychotherapy and Psychosomatics, 77, 337-350.